Secondary analysis nested in an RCT, 563 of 1,272 children followed to 5 years: neonatal BCG did not significantly reduce herpes labialis vs no BCG (5% vs 8%, p=0.1), though recurrence was lower in those affected (33% vs 71%, p=0.02). Exploratory.
Secondary analysisn = 563 children
Pittet et al. Effect of neonatal BCG vaccination on oral herpes in early childhood: A nested study within a randomised controlled trial